Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

BACKGROUND: In the multi-country PROMISE 1077BF trial, the risk of low birth weight (LBW; <2500g) and preterm delivery (PTD; <37 weeks) was higher among women initiating a protease inhibitor (PI)-based antiretroviral treatment (ART) regimen than in those receiving ZDV alone. Among those assign...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Acquir Immune Defic Syndr
Main Authors: Sebikari, Dorothy, Farhad, Mona, Fenton, Terry, Owor, Maxensia, Stringer, Jeffrey S. A., Qin, Min, Chakhtoura, Nahida, Chi, Benjamin H., Saidi, Friday, Nevrekar, Neetal, Violari, Avy, Chipato, Tsungai, McIntyre, James A., Moodley, Dhayendre, Taha, Taha E., Theron, Gerhard, Fowler, Mary Glenn
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702964/
https://ncbi.nlm.nih.gov/pubmed/31295174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002072
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki